臨床試驗

A Clinical Trial to Assess the Agent Paclitaxel Coated PTCA Balloon Catheter for the Treatment of Subjects With In-Stent Restenosis (ISR)

NCT：NCT04647253 · ACTIVE_NOT_RECRUITING

NCT IDNCT04647253

狀態ACTIVE_NOT_RECRUITING

開始日期2021-05-11

SponsorBoston Scientific Corporation (INDUSTRY)

First posted2020-11-30

Last updated2026-09-18

簡要摘要

AGENT IDE is a Prospective, Randomized (2:1), Multicenter Trial. The purpose of this study is to assess the safety and effectiveness of the Agent Paclitaxel Coated PTCA Balloon Catheter compared to balloon angioplasty (POBA) in patients with in-stent restenosis (ISR) of a previously treated lesion of up to 26 mm in length (by visual estimate) in a native coronary artery 2.0 mm to 4.0 mm in diameter.

官方來源

在 ClinicalTrials.gov 上查看 →

資料來自 ClinicalTrials.gov API。最新狀態請參閱官方紀錄。